Search
Returning search results with filters:
Remove filter for
Audience: General public
Remove filter for
Category: Drugs
Remove filter for
Type: Information update
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 15 of 26 items.
Certain Metformin diabetes drugs recalled due to the presence or possible presence of NDMA
AlertInformation update | 2020-06-13
Alcohol, Cannabis and Drug Use During the Holiday Season
AlertInformation update | 2019-12-17
Health Canada assessing NDMA in ranitidine
AlertInformation update | 2019-09-13
Pfizer Canada is reporting a shortage of EpiPen (0.3 mg) auto-injectors and taking precautions to minimize impact on Canadians
AlertInformation update | 2019-07-19
Substance use during summer events and festivals
AlertInformation update | 2019-06-20
Health Canada warns Canadians of potential cancer risk associated with gentian violet
AlertInformation update | 2019-06-12
Testing finds pharmaceutical ingredients in unauthorized health products seized from Sunrise Lee Chinese Herbs Centre in Calgary, Alberta
AlertInformation update | 2019-05-08
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
AlertInformation update | 2019-03-09
Health Canada recommends that children and youth not use cough and cold products that contain opioids
AlertInformation update | 2019-02-18
Important new safety information regarding the use of hydrochlorothiazide and the risk of non-melanoma skin cancer
AlertInformation update | 2019-01-31
Health Canada releases test results of certain sartan drugs
AlertInformation update | 2018-12-20
Cannabis and Alcohol Use During the Holidays
AlertInformation update | 2018-12-17
Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity
AlertInformation update | 2018-11-28
Summary Safety Review: Health Canada concludes that there are no new safety concerns with sunscreen products
AlertInformation update | 2018-11-26